Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? Equity (Unaudited)

v3.25.0.1
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Preferred Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Non-Controlling Interest
Beginning balance, common (in shares) at Mar. 31, 2023   99,458,369            
Beginning balance at Mar. 31, 2023 $ 607,255 $ 10 $ 100 $ (71) $ 822,217 $ (41,945) $ (175,115) $ 2,059
Beginning balance, preferred (in shares) at Mar. 31, 2023     100,000          
Beginning balance, treasury (in shares) at Mar. 31, 2023       758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income (8,399)           (8,179) (220)
Foreign currency translation (6,107)         (6,846)   739
Stock-based compensation expense 10,017       10,017      
Shares issued:                
Exercise of stock options (in shares)   378,507            
Exercise of stock options 731       731      
Issuance of restricted shares and vesting of restricted units (in shares)   449,781            
Acquisition of non-controlling interests in Fyber (3,751)       (1,173)     (2,578)
Payment of withholding taxes related to the net share settlement of equity awards (931)       (931)      
Ending balance, common (in shares) at Jun. 30, 2023   100,286,657            
Ending balance at Jun. 30, 2023 598,815 $ 10 $ 100 $ (71) 830,861 (48,791) (183,294) 0
Ending balance, preferred (in shares) at Jun. 30, 2023     100,000          
Ending balance, treasury (in shares) at Jun. 30, 2023       758,125        
Beginning balance, common (in shares) at Mar. 31, 2023   99,458,369            
Beginning balance at Mar. 31, 2023 607,255 $ 10 $ 100 $ (71) 822,217 (41,945) (175,115) 2,059
Beginning balance, preferred (in shares) at Mar. 31, 2023     100,000          
Beginning balance, treasury (in shares) at Mar. 31, 2023       758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income (183,942)              
Foreign currency translation (3,809)              
Ending balance, common (in shares) at Dec. 31, 2023   101,696,143            
Ending balance at Dec. 31, 2023 445,698 $ 10 $ 100 $ (71) 850,989 (46,493) (358,837) 0
Ending balance, preferred (in shares) at Dec. 31, 2023     100,000          
Ending balance, treasury (in shares) at Dec. 31, 2023       758,125        
Beginning balance, common (in shares) at Jun. 30, 2023   100,286,657            
Beginning balance at Jun. 30, 2023 598,815 $ 10 $ 100 $ (71) 830,861 (48,791) (183,294) 0
Beginning balance, preferred (in shares) at Jun. 30, 2023     100,000          
Beginning balance, treasury (in shares) at Jun. 30, 2023       758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income (161,482)           (161,482)  
Foreign currency translation (1,287)         (1,287)    
Stock-based compensation expense 9,924       9,924      
Shares issued:                
Exercise of stock options (in shares)   575,599            
Exercise of stock options 1,998       1,998      
Issuance of restricted shares and vesting of restricted units (in shares)   226,890            
Payment of withholding taxes related to the net share settlement of equity awards (106)       (106)      
Ending balance, common (in shares) at Sep. 30, 2023   101,089,146            
Ending balance at Sep. 30, 2023 447,862 $ 10 $ 100 $ (71) 842,677 (50,078) (344,776) 0
Ending balance, preferred (in shares) at Sep. 30, 2023     100,000          
Ending balance, treasury (in shares) at Sep. 30, 2023       758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income (14,061)           (14,061) 0
Foreign currency translation 3,585         3,585   0
Stock-based compensation expense 8,395       8,395      
Shares issued:                
Exercise of stock options (in shares)   29,225            
Exercise of stock options 57       57      
Issuance of restricted shares and vesting of restricted units (in shares)   577,772            
Payment of withholding taxes related to the net share settlement of equity awards (140)       (140)      
Ending balance, common (in shares) at Dec. 31, 2023   101,696,143            
Ending balance at Dec. 31, 2023 $ 445,698 $ 10 $ 100 $ (71) 850,989 (46,493) (358,837) $ 0
Ending balance, preferred (in shares) at Dec. 31, 2023     100,000          
Ending balance, treasury (in shares) at Dec. 31, 2023       758,125        
Beginning balance, common (in shares) at Mar. 31, 2024 102,118,932 102,118,932            
Beginning balance at Mar. 31, 2024 $ 213,932 $ 10 $ 100 $ (71) 858,191 (48,955) (595,343)  
Beginning balance, preferred (in shares) at Mar. 31, 2024 100,000   100,000          
Beginning balance, treasury (in shares) at Mar. 31, 2024 758,125     758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income $ (25,156)           (25,156)  
Foreign currency translation (1,213)         (1,213)    
Stock-based compensation expense 8,424       8,424      
Shares issued:                
Exercise of stock options (in shares)   8,599            
Exercise of stock options 14       14      
Issuance of restricted shares and vesting of restricted units (in shares)   390,752            
Payment of withholding taxes related to the net share settlement of equity awards (48)       (48)      
Ending balance, common (in shares) at Jun. 30, 2024   102,518,283            
Ending balance at Jun. 30, 2024 $ 195,953 $ 10 $ 100 $ (71) 866,581 (50,168) (620,499)  
Ending balance, preferred (in shares) at Jun. 30, 2024     100,000          
Ending balance, treasury (in shares) at Jun. 30, 2024       758,125        
Beginning balance, common (in shares) at Mar. 31, 2024 102,118,932 102,118,932            
Beginning balance at Mar. 31, 2024 $ 213,932 $ 10 $ 100 $ (71) 858,191 (48,955) (595,343)  
Beginning balance, preferred (in shares) at Mar. 31, 2024 100,000   100,000          
Beginning balance, treasury (in shares) at Mar. 31, 2024 758,125     758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income $ (73,273)              
Foreign currency translation $ (3,175)              
Shares issued:                
Exercise of stock options (in shares) 19,849              
Ending balance, common (in shares) at Dec. 31, 2024 104,834,978 104,834,978            
Ending balance at Dec. 31, 2024 $ 163,563 $ 10 $ 100 $ (71) 884,270 (52,130) (668,616)  
Ending balance, preferred (in shares) at Dec. 31, 2024 100,000   100,000          
Ending balance, treasury (in shares) at Dec. 31, 2024 758,125     758,125        
Beginning balance, common (in shares) at Jun. 30, 2024   102,518,283            
Beginning balance at Jun. 30, 2024 $ 195,953 $ 10 $ 100 $ (71) 866,581 (50,168) (620,499)  
Beginning balance, preferred (in shares) at Jun. 30, 2024     100,000          
Beginning balance, treasury (in shares) at Jun. 30, 2024       758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income (24,986)           (24,986)  
Foreign currency translation 2,157         2,157    
Stock-based compensation expense 9,279       9,279      
Shares issued:                
Exercise of stock options (in shares)   1,667            
Exercise of stock options 79       79      
Issuance of restricted shares and vesting of restricted units (in shares)   1,001,502            
Payment of withholding taxes related to the net share settlement of equity awards (112)       (112)      
Ending balance, common (in shares) at Sep. 30, 2024   103,521,452            
Ending balance at Sep. 30, 2024 182,370 $ 10 $ 100 $ (71) 875,827 (48,011) (645,485)  
Ending balance, preferred (in shares) at Sep. 30, 2024     100,000          
Ending balance, treasury (in shares) at Sep. 30, 2024       758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income (23,131)           (23,131)  
Foreign currency translation (4,119)         (4,119)    
Stock-based compensation expense 8,504       8,504      
Shares issued:                
Exercise of stock options (in shares)   9,537            
Exercise of stock options 10       10      
Issuance of restricted shares and vesting of restricted units (in shares)   1,303,989            
Payment of withholding taxes related to the net share settlement of equity awards $ (71)       (71)      
Ending balance, common (in shares) at Dec. 31, 2024 104,834,978 104,834,978            
Ending balance at Dec. 31, 2024 $ 163,563 $ 10 $ 100 $ (71) $ 884,270 $ (52,130) $ (668,616)  
Ending balance, preferred (in shares) at Dec. 31, 2024 100,000   100,000          
Ending balance, treasury (in shares) at Dec. 31, 2024 758,125     758,125